TY - JOUR
T1 - Factors influencing community pharmacists’ knowledge about women’s issues in epilepsy
AU - Jairoun, Ammar Abdulrahman
AU - Al-himyari, Sabba Saleh
AU - Shahwan, Moyad
AU - Hassan, Nageeb
AU - AL-Tamimi, Saleh
AU - Jairoun, Maimona
AU - Zyoud, Saed H.
AU - Alshehri, Abdullah S.
AU - Alkhanani, Mustfa Faisal
AU - Alhasani, Reem Hasaballah
AU - Alharbi, Adnan S.
AU - Alshehri, Fahad S.
AU - Ashour, Ahmed M.
AU - Alorfi, Nasser M.
N1 - Publisher Copyright:
Copyright © 2023 Jairoun, Al-himyari, Shahwan, Hassan, AL-Tamimi, Jairoun, Zyoud, Alshehri, Alkhanani, Alhasani, Alharbi, Alshehri, Ashour and Alorfi.
PY - 2023
Y1 - 2023
N2 - Background: Previous studies have highlighted instances where pharmacists lacked knowledge regarding women’s health issues related to epilepsy. Objectives: To assess UAE community pharmacists’ knowledge, toward women’s issues in epilepsy. Methods: a cross-sectional research method was employed. A team of seven pharmacy students in their final year visited a randomly selected sample of community pharmacies in the UAE and face-to-face interviews were conducted with the pharmacists using a structured questionnaire. The questionnaire includes two parts; Eight questions designed to elicit data about the demographics of the study participants and 12 questions eliciting insights into the participants’ knowledge of women’s issues in epilepsy. Results: A total of 412 community pharmacist were recruited in the study. The overall level of knowledge about women’s issues in epilepsy was good and the average knowledge score was 81% with a 95% confidence interval (CI) [79.1, 82.7%]. The results of multivariate analysis showed higher knowledge scores in chain pharmacies (OR 1.37; 95% CI 1.12–1.67), Chief pharmacists (OR 1.44; 95% CI 1.01–2.06), Pharmacists in charge (OR 3.46; 95% CI 2.7–4.45), pharmacists with 1–5 Years of experience (OR 2.87; 95% CI 1.71–4.82), pharmacists with 6–10 Years (OR 2.63; 95% CI 1.58–4.38), pharmacists with >10 years (OR 3.13; 95% CI 2.03–4.83), graduation form regional universities (OR 1.37; 95% CI 1.12–1.67), graduation form international universities (OR 1.73; 95% CI 1.36–2.20) and receiving a training on epilepsy (OR 1.36; 95% CI 1.12–1.67). Conclusion: While the findings reveal an overall promising level of knowledge among community pharmacists regarding the issues faced by women with epilepsy, pinpointing which clinical and demographic factors have the most significant impact on this knowledge would permit the implementation of tailored educational interventions. Workshops and modules targeting the issues faced by women with epilepsy would further raise the knowledge and competence among community pharmacists in this area, ensuring better pharmaceutical care for this population.
AB - Background: Previous studies have highlighted instances where pharmacists lacked knowledge regarding women’s health issues related to epilepsy. Objectives: To assess UAE community pharmacists’ knowledge, toward women’s issues in epilepsy. Methods: a cross-sectional research method was employed. A team of seven pharmacy students in their final year visited a randomly selected sample of community pharmacies in the UAE and face-to-face interviews were conducted with the pharmacists using a structured questionnaire. The questionnaire includes two parts; Eight questions designed to elicit data about the demographics of the study participants and 12 questions eliciting insights into the participants’ knowledge of women’s issues in epilepsy. Results: A total of 412 community pharmacist were recruited in the study. The overall level of knowledge about women’s issues in epilepsy was good and the average knowledge score was 81% with a 95% confidence interval (CI) [79.1, 82.7%]. The results of multivariate analysis showed higher knowledge scores in chain pharmacies (OR 1.37; 95% CI 1.12–1.67), Chief pharmacists (OR 1.44; 95% CI 1.01–2.06), Pharmacists in charge (OR 3.46; 95% CI 2.7–4.45), pharmacists with 1–5 Years of experience (OR 2.87; 95% CI 1.71–4.82), pharmacists with 6–10 Years (OR 2.63; 95% CI 1.58–4.38), pharmacists with >10 years (OR 3.13; 95% CI 2.03–4.83), graduation form regional universities (OR 1.37; 95% CI 1.12–1.67), graduation form international universities (OR 1.73; 95% CI 1.36–2.20) and receiving a training on epilepsy (OR 1.36; 95% CI 1.12–1.67). Conclusion: While the findings reveal an overall promising level of knowledge among community pharmacists regarding the issues faced by women with epilepsy, pinpointing which clinical and demographic factors have the most significant impact on this knowledge would permit the implementation of tailored educational interventions. Workshops and modules targeting the issues faced by women with epilepsy would further raise the knowledge and competence among community pharmacists in this area, ensuring better pharmaceutical care for this population.
KW - antiepileptic drugs
KW - community pharmacist
KW - epilepsy
KW - knowledge
KW - optimal seizure control
KW - women’s issues in epilepsy
UR - https://www.scopus.com/pages/publications/85172010779
U2 - 10.3389/fpubh.2023.1251393
DO - 10.3389/fpubh.2023.1251393
M3 - Article
C2 - 37766744
AN - SCOPUS:85172010779
SN - 2296-2565
VL - 11
JO - Frontiers in Public Health
JF - Frontiers in Public Health
M1 - 1251393
ER -